New this week in PubMed from CPI Institute

  • Alhathli E, Julian T, Girach ZUA, Thompson AaR, Rhodes C, Gräf S, Errington N, Wilkins MR, Lawrie A, Wang D, Cooper-Knock J. Mendelian Randomization Study With Clinical Follow-Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension. J Am Heart Assoc:e032256, 2024.

 

  • Krause NM, Kaur Bains J, Blechar J, Richter C, Bessi I, Grote P, Leisegang M, Brandes RP, Schwalbe H. Biophysical Investigation of RNA•DNA:DNA triple helix and RNA:DNA heteroduplex formation by the lncRNAs MEG3 and Fendrr. Chembiochem:e202400049, 2024.

 

  • Meertens MM, Adam M, Beckmann A, Ensminger S, Frerker C, Seiffert M, Sinning JM, Bekeredjian R, Walther T, Beyersdorf F, Möllmann H, Balaban Ü, Eghbalzadeh K, Rudolph TK, Bleiziffer S. Non-femoral focused transaxillary access in TAVI: GARY data analysis and future trends. Clin Res Cardiol, 2024.

 

  • Raspe M, Lo K, Sommer N, Andreas S. [Tobacco cessation: one of the most effective medical measures]. Inn Med (Heidelb), 2024.

 

  • Woolf B, Perry JA, Hong CC, Wilkins MR, Toshner M, Gill D, Burgess S, Rhodes CJ. Multi-biobank summary data Mendelian randomisation does not support a causal effect of IL-6 signalling on risk of pulmonary arterial hypertension. Eur Respir J, 2024. letter

 

  • Xu S, Offermanns S. Endothelial lipid droplets drive atherosclerosis and arterial hypertension. Trends Endocrinol Metab, 2024.

New in PubMed in Archive